Get ready for Quentin Tarantino's 'Kill Bill: The Whole Bloody Affair' as it hits theaters on Dec. 5! This epic version combines both films and features a new anime sequence—don't miss the trailer!
The USDA is set to comply with a federal judge's order to provide full food benefits to 42 million Americans despite a government shutdown. Confusion remains as the Justice Department appeals the decision.
President Trump warns that losing a Supreme Court case could devastate his tariff policies, which have raised billions. Explore how he plans to adapt if the court rules against him.
As migratory birds carry the H5N1 virus south, millions of poultry have already perished. Experts warn of potential human infections and a lack of federal oversight in monitoring the virus.
The U.S. faces its longest government shutdown, impacting millions of federal workers and essential programs like SNAP and Head Start. As Thanksgiving approaches, air travel chaos looms if the deadlock continues.
President Trump's tariffs, once hailed as a money-making cure-all, are now revealed to be primarily regulatory, sparking controversy and concern over legal authority and economic implications.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.
In a landmark ruling, a federal judge mandates the Trump administration to fully fund SNAP benefits for November, rejecting partial funding during the government shutdown. Millions of Americans at risk of hunger will now receive necessary support.
Jaafar Jackson showcases his incredible dance skills in the teaser for the Michael Jackson biopic directed by Antoine Fuqua. Set to release on April 24, 2026, this film promises an intimate look at the King of Pop's life beyond his iconic music.
In a groundbreaking move, President Trump announces deals with Eli Lilly and Novo Nordisk to reduce obesity drug prices, making treatments more accessible for millions of Americans. Medicare coverage for GLP-1 drugs starts in 2026, changing the landscape of obesity treatment.
